Mitochondrial and glucose metabolic dysfunctions in granulosa cells induce impaired oocytes of polycystic ovary syndrome through Sirtuin 3
- PMID: 35594990
- DOI: 10.1016/j.freeradbiomed.2022.05.010
Mitochondrial and glucose metabolic dysfunctions in granulosa cells induce impaired oocytes of polycystic ovary syndrome through Sirtuin 3
Abstract
Mitochondrial function and glucose metabolism play important roles in bidirectional signaling between granulosa cells (GCs) and oocytes. However, the factors associated with mitochondrial function and glucose metabolism of GCs in polycystic ovary syndrome (PCOS) are poorly understood, and their potential downstream effects on oocyte quality are still unknown. The aim of this study was to investigate whether there are alterations in mitochondrial-related functions and glucose metabolism in ovarian GCs of women with PCOS and the role of Sirtuin 3 (SIRT3) in this process. Here, we demonstrated that women with PCOS undergoing in vitro fertilization and embryo transfer had significantly lower rates of metaphase II oocytes, two-pronuclear fertilization, cleavage, and day 3 good-quality embryos. Germinal vesicle- and metaphase I-stage oocytes from women with PCOS exhibited increased mitochondrial reactive oxygen species (ROS), decreased mitochondrial membrane potential, and downregulation of glucose-6-phosphate dehydrogenase. GCs from women with PCOS presented significant alterations in mitochondrial morphology, amount, and localization, decreased membrane potential, reduced adenosine triphosphate (ATP) synthesis, increased mitochondrial ROS and oxidative stress, and insufficient oxidative phosphorylation (OXPHOS) together with decreased glycolysis. SIRT3 expression was significantly decreased in GCs of PCOS patients, and knockdown of SIRT3 in KGN cells could mimic the alterations in mitochondrial functions and glucose metabolism in PCOS GCs. SIRT3 knockdown changed the acetylation status of NDUFS1, which might induce altered mitochondrial OXPHOS, the generation of mitochondrial ROS, and eventually defects in the cellular insulin signaling pathway. These findings suggest that SIRT3 deficiency in GCs of PCOS patients may contribute to mitochondrial dysfunction, elevated oxidative stress, and defects in glucose metabolism, which potentially induce impaired oocytes in PCOS.
Keywords: Glucose metabolism; Granulosa cells; Mitochondria; Oocyte quality; Polycystic ovary syndrome; Sirtuin 3.
Copyright © 2022 Elsevier Inc. All rights reserved.
Similar articles
-
Chinese herbal medicine alleviates the pathogenesis of polycystic ovary syndrome by improving oxidative stress and glucose metabolism via mitochondrial Sirtuin 3 signaling.Phytomedicine. 2023 Jan;109:154556. doi: 10.1016/j.phymed.2022.154556. Epub 2022 Nov 18. Phytomedicine. 2023. PMID: 36610149
-
The effects of mitochondrial dysfunction on energy metabolism switch by HIF-1α signalling in granulosa cells of polycystic ovary syndrome.Endokrynol Pol. 2020;71(2):134-145. doi: 10.5603/EP.a2020.0002. Epub 2020 Feb 25. Endokrynol Pol. 2020. PMID: 32096549
-
Correlation between abnormal energy metabolism of ovarian granulosa cells and in vitro fertilization-embryo transfer outcomes in patients with polycystic ovary syndrome and obesity.J Ovarian Res. 2023 Jul 21;16(1):145. doi: 10.1186/s13048-023-01204-3. J Ovarian Res. 2023. PMID: 37480140 Free PMC article.
-
Essential Role of Granulosa Cell Glucose and Lipid Metabolism on Oocytes and the Potential Metabolic Imbalance in Polycystic Ovary Syndrome.Int J Mol Sci. 2023 Nov 13;24(22):16247. doi: 10.3390/ijms242216247. Int J Mol Sci. 2023. PMID: 38003436 Free PMC article. Review.
-
Oxidative stress and energy metabolism abnormalities in polycystic ovary syndrome: from mechanisms to therapeutic strategies.Reprod Biol Endocrinol. 2024 Dec 26;22(1):159. doi: 10.1186/s12958-024-01337-0. Reprod Biol Endocrinol. 2024. PMID: 39722030 Free PMC article. Review.
Cited by
-
Mitoguardin2 Is Associated With Hyperandrogenism and Regulates Steroidogenesis in Human Ovarian Granulosa Cells.J Endocr Soc. 2023 Feb 28;7(5):bvad034. doi: 10.1210/jendso/bvad034. eCollection 2023 Mar 6. J Endocr Soc. 2023. PMID: 36936714 Free PMC article.
-
Mechanisms of Granulosa Cell Programmed Cell Death and Follicular Atresia in Polycystic Ovary Syndrome.Physiol Res. 2025 Mar 21;74(1):31-40. doi: 10.33549/physiolres.935485. Physiol Res. 2025. PMID: 40116548 Free PMC article. Review.
-
SIRT3 ameliorates polycystic ovary syndrome through FOXO1/PGC-1α signaling pathway.Endocrine. 2023 Apr;80(1):201-211. doi: 10.1007/s12020-022-03262-x. Epub 2023 Jan 4. Endocrine. 2023. PMID: 36598711
-
Current Advances in Cellular Approaches for Pathophysiology and Treatment of Polycystic Ovary Syndrome.Cells. 2023 Aug 31;12(17):2189. doi: 10.3390/cells12172189. Cells. 2023. PMID: 37681921 Free PMC article. Review.
-
New insights into the treatment of polycystic ovary syndrome: HKDC1 promotes the growth of ovarian granulocyte cells by regulating mitochondrial function and glycolysis.J Mol Histol. 2024 Apr;55(2):187-199. doi: 10.1007/s10735-024-10183-8. Epub 2024 Mar 13. J Mol Histol. 2024. PMID: 38478190
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous